학술논문

Canakinumab in a subgroup of patients with COVID-19
Document Type
Correspondence
Source
In The Lancet Rheumatology August 2020 2(8):e457-ee458
Subject
Analysis and Interpretation
Correspondence
Language
ISSN
2665-9913